Edit |   |
---|---|
Antigenic Specificity | SLAMF9 (C-term), 242-270 |
Clone | polyclonal |
Host Species | Rabbit |
Reactive Species | human |
Isotype | n/a |
Format | peptide affinity purified |
Size | 0.08 mL, 0.4 mL |
Concentration | vial concentration: 0.5 |
Applications | Western Blot (WB), ELISA (EIA) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | This SLAMF9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 242-270 amino acids from the C-terminal region of human SLAMF9. SLAMF9 is a member of the signaling lymphocyticactivation molecule family. The encoded protein is a cell surfacemolecule that consists of two extracellular immunoglobulin domains,a transmembrane domain and a short cytoplasmic tail that lacks thesignal transduction motifs found in other family members. |
Immunogen | n/a |
Other Names | [SLAM family member 9; CD2 family member 10; CD2F-10; CD84 homolog 1; CD84-H1; SLAMF9; CD2F10] |
Gene, Accession # | [SLAMF9], Gene ID: 89886, NCBI: NP_001139644.1, UniProt: Q96A28 |
Catalog # | MBS9205729 |
Price | $165, $370 |
Order / More Info | SLAMF9 (C-term), 242-270 Antibody from MYBIOSOURCE INC. |
Product Specific References | Calpe, S., et al. Adv. Immunol. 97, 177-250 (2008) : Fraser, C.C., et al. Immunogenetics 53 (10-11), 843-850 (2002) : Fennelly, J.A., et al. Immunogenetics 53(7):599-602(2001) Zhang, W., et al. Clin. Cancer Res. 7 (3 SUPPL), 822S-829S (2001) : |